Klidjian A M, Swift P G, Johnstone J M
Arch Dis Child. 1985 Jun;60(6):568-71. doi: 10.1136/adc.60.6.568.
Forty boys with 54 incompletely descended testes took part in a double blind, controlled trial of intranasal luteinising hormone releasing hormone. In the control (placebo) group of 18 boys there was no significant change in testicular descent and all required orchidopexy; in the 22 treated boys, however, 12 of 29 testes (42%) were found in a lower position. This study supports the idea that a trial of intranasal luteinising hormone releasing hormone (1200 micrograms/day for 28 days) will help clarify the need for orchidopexy in at least 30% of boys with incomplete descent of the testis, particularly those in whom the testes have emerged from the inguinal canal.
40名患有54个隐睾的男孩参与了一项关于鼻内促黄体生成素释放激素的双盲对照试验。在18名男孩的对照组(安慰剂组)中,睾丸下降情况无显著变化,所有患儿均需进行睾丸固定术;然而,在22名接受治疗的男孩中,29个睾丸中有12个(42%)位置下移。该研究支持这样一种观点,即鼻内促黄体生成素释放激素试验(每日1200微克,持续28天)将有助于明确至少30%的隐睾男孩,尤其是那些睾丸已从腹股沟管降出的男孩是否需要进行睾丸固定术。